Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David T Teachey

Showing results (31-40 of 214) with videos related to

Pageof 22
Sort By:
Hematology. American Society of Hematology. Education Program|December 4, 2016
T-cell acute lymphoblastic leukemiaElizabeth A Raetz, David T Teachey
The Lancet. Oncology|March 8, 2019
Comparative features and outcomes between paediatric T-cell and B-cell acute lymphoblastic leukaemiaDavid T Teachey, Ching-Hon Pui
Expert Review of Clinical Immunology|June 21, 2019
Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndromeChelsea Kotch, David Barrett, David T Teachey
Blood Advances|December 12, 2025
A new sUSPect in T-ALL risk stratificationStephanie J Si Lim, David T Teachey
Haematologica|January 9, 2025
Relapsed childhood T-cell acute lymphoblastic leukemia and lymphoblastic lymphomaAndrew D Hughes, Petri Pölönen, David T Teachey
Expert Review of Hematology|July 23, 2016
The role of proteasome inhibition in the treatment of malignant and non-malignant hematologic disordersRebecca Citrin, Jessica B Foster, David T Teachey
Clinical Lymphoma, Myeloma & Leukemia|May 17, 2026
SOHO State of the Art Updates and Next Questions: Novel Therapies in T-ALL: From CAR-T to Novel TargetsRyan J Summers, Haley Newman, David T Teachey
The Journal of Allergy and Clinical Immunology. in Practice|March 29, 2023
Cytokine Storm Syndromes in Pediatric PatientsCaroline Diorio, David T Teachey, Scott W Canna
Nature Reviews. Clinical Oncology|November 15, 2024
Allogeneic chimeric antigen receptor cell therapies for cancer: progress made and remaining roadblocksCaroline Diorio, David T Teachey, Stephan A Grupp
Expert Review of Clinical Immunology|September 25, 2020
Chimeric antigen receptor T cell therapy for pediatric and young adult B cell acute lymphoblastic leukemiaRegina M Myers, Joseph Dolan, David T Teachey
Pageof 22

Showing results (31-40 of 214) with videos related to

Sort By:
Pageof 22
Hematology. American Society of Hematology. Education Program|December 4, 2016
T-cell acute lymphoblastic leukemiaElizabeth A Raetz, David T Teachey
The Lancet. Oncology|March 8, 2019
Comparative features and outcomes between paediatric T-cell and B-cell acute lymphoblastic leukaemiaDavid T Teachey, Ching-Hon Pui
Expert Review of Clinical Immunology|June 21, 2019
Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndromeChelsea Kotch, David Barrett, David T Teachey
Blood Advances|December 12, 2025
A new sUSPect in T-ALL risk stratificationStephanie J Si Lim, David T Teachey
Haematologica|January 9, 2025
Relapsed childhood T-cell acute lymphoblastic leukemia and lymphoblastic lymphomaAndrew D Hughes, Petri Pölönen, David T Teachey
Expert Review of Hematology|July 23, 2016
The role of proteasome inhibition in the treatment of malignant and non-malignant hematologic disordersRebecca Citrin, Jessica B Foster, David T Teachey
Clinical Lymphoma, Myeloma & Leukemia|May 17, 2026
SOHO State of the Art Updates and Next Questions: Novel Therapies in T-ALL: From CAR-T to Novel TargetsRyan J Summers, Haley Newman, David T Teachey
The Journal of Allergy and Clinical Immunology. in Practice|March 29, 2023
Cytokine Storm Syndromes in Pediatric PatientsCaroline Diorio, David T Teachey, Scott W Canna
Nature Reviews. Clinical Oncology|November 15, 2024
Allogeneic chimeric antigen receptor cell therapies for cancer: progress made and remaining roadblocksCaroline Diorio, David T Teachey, Stephan A Grupp
Expert Review of Clinical Immunology|September 25, 2020
Chimeric antigen receptor T cell therapy for pediatric and young adult B cell acute lymphoblastic leukemiaRegina M Myers, Joseph Dolan, David T Teachey
Pageof 22